Related Experiment Video

Updated: May 20, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

1.8K

The untold story of CD82: Exploring its non-canonical roles in cancer

Shutao Zheng1, Yao Zhang2, Ren Cai1

  • 1State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region 830011, PR China.

Pathology, Research and Practice
|April 19, 2025
PubMed

Insights

CD82, a metastasis suppressor, has new roles in cancer progression, influencing immune cells and the tumor microenvironment. Research shows CD82

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • CD82, a tetraspanin protein, is traditionally known for its metastasis suppressor function in cancer.
  • Emerging evidence indicates CD82 possesses non-canonical roles significantly impacting cancer progression.
  • These novel functions extend beyond its established role, influencing critical cellular processes in cancer.

Purpose of the Study:

  • To review and synthesize recent research on the non-canonical functions of CD82 in cancer.
  • To highlight CD82's role in regulating immune cell interactions and modulating the tumor microenvironment.
  • To explore CD82's potential as a therapeutic target and a biomarker for cancer diagnosis and treatment.

Main Methods:

  • Literature review of recent studies on CD82 in cancer.
  • Analysis of research focusing on CD82's impact on immune modulation and signaling pathways.
  • Synthesis of findings related to CD82's therapeutic and diagnostic potential.

Main Results:

  • CD82 actively regulates immune cell interactions within the tumor microenvironment.
  • CD82 influences key signaling pathways involved in cancer progression.
  • The protein demonstrates potential as both a therapeutic target and a diagnostic biomarker.

Conclusions:

  • CD82 exhibits significant non-canonical roles in cancer, extending beyond metastasis suppression.
  • Its involvement in immune modulation and the tumor microenvironment offers new therapeutic strategies.
  • CD82 holds promise for improving cancer diagnosis and developing novel therapeutic interventions.
Keywords:
CD82CanonicalComplexMicroenvironmentNon-canonical

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

9.9K
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

791

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
617
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K